Waltham, MA, United States of America

Qibin Su

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Waltham, MA (US) (2017 - 2022)
  • Wilmington, DE (US) (2021 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Qibin Su: A Trailblazer in Pharmaceutical Innovation

Introduction

Qibin Su, based in Waltham, MA, is a notable inventor with a strong focus on developing innovative pharmaceutical compounds. With five patents to his name, he has made significant contributions to the field of drug discovery, particularly in the treatment of JAK-related disorders.

Latest Patents

Among his latest patents, Qibin has disclosed compounds for inhibiting JAK, which includes pharmaceutical compositions featuring these compounds. His inventions are aimed at treating various JAK-related disorders, including cancer, cancer cachexia, and immune disorders. Additionally, he has developed JAK1 selective inhibitors, presenting compounds alongside their pharmaceutically acceptable salts, demonstrating their potential in medicinal applications.

Career Highlights

Qibin has worked with well-known companies in the pharmaceutical industry, such as Dizal Pharmaceutical Co., Ltd. and AstraZeneca Ab, where he has been instrumental in advancing drug formulations and therapies. His experience within these leading organizations has complemented his inventive prowess, positioning him as a key contributor in pharmaceutical research and development.

Collaborations

During his career, Qibin has collaborated with talented professionals, including Sameer Pralhad Kawatkar and Jason Grant Kettle. Together, they have worked on pioneering research initiatives, fostering an environment of innovation and scientific exploration.

Conclusion

Qibin Su's dedication to pharmaceutical innovation has led him to create impactful solutions for various medical disorders. With a portfolio of five patents, he continues to enhance the landscape of drug discovery, making strides that may benefit countless patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…